Cargando…

Carcinogenic effect of potassium octatitanate (POT) fibers in the lung and pleura of male Fischer 344 rats after intrapulmonary administration

BACKGROUND: Potassium octatitanate fibers (K(2)O•8TiO(2), POT fibers) are used as an asbestos substitute. Their physical characteristics suggest that respirable POT fibers are likely to be carcinogenic in the lung and pleura. However, previous 2-year inhalation studies reported that respired POT fib...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelgied, Mohamed, El-Gazzar, Ahmed M., Alexander, William T., Numano, Takamasa, Iigou, Masaaki, Naiki-Ito, Aya, Takase, Hiroshi, Hirose, Akihiko, Taquahashi, Yuhji, Kanno, Jun, Abdelhamid, Mona, Abdou, Khaled Abbas, Takahashi, Satoru, Alexander, David B., Tsuda, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720102/
https://www.ncbi.nlm.nih.gov/pubmed/31477126
http://dx.doi.org/10.1186/s12989-019-0316-2
_version_ 1783448052787314688
author Abdelgied, Mohamed
El-Gazzar, Ahmed M.
Alexander, William T.
Numano, Takamasa
Iigou, Masaaki
Naiki-Ito, Aya
Takase, Hiroshi
Hirose, Akihiko
Taquahashi, Yuhji
Kanno, Jun
Abdelhamid, Mona
Abdou, Khaled Abbas
Takahashi, Satoru
Alexander, David B.
Tsuda, Hiroyuki
author_facet Abdelgied, Mohamed
El-Gazzar, Ahmed M.
Alexander, William T.
Numano, Takamasa
Iigou, Masaaki
Naiki-Ito, Aya
Takase, Hiroshi
Hirose, Akihiko
Taquahashi, Yuhji
Kanno, Jun
Abdelhamid, Mona
Abdou, Khaled Abbas
Takahashi, Satoru
Alexander, David B.
Tsuda, Hiroyuki
author_sort Abdelgied, Mohamed
collection PubMed
description BACKGROUND: Potassium octatitanate fibers (K(2)O•8TiO(2), POT fibers) are used as an asbestos substitute. Their physical characteristics suggest that respirable POT fibers are likely to be carcinogenic in the lung and pleura. However, previous 2-year inhalation studies reported that respired POT fibers had little or no carcinogenic potential. In the present study ten-week old male F344 rats were left untreated or were administered vehicle, 0.25 or 0.5 mg rutile-type nano TiO(2) (r-nTiO(2)), 0.25 or 0.5 mg POT fibers, or 0.5 mg MWCNT-7 by intra-tracheal intra-pulmonary spraying (TIPS), and then observed for 2 years. RESULTS: There were no differences between the r-nTiO(2) and control groups. The incidence of bronchiolo-alveolar cell hyperplasia was significantly increased in the groups treated with 0.50 mg POT and 0.50 mg MWCNT-7. The overall incidence of lung tumors, however, was not increased in either the POT or MWCNT-7 treated groups. Notably, the carcinomas that developed in the POT and MWCNT-7 treated rats were accompanied by proliferative fibrous connective tissue while the carcinomas that developed in the untreated rats and the r-nTiO(2) treated rats were not (carcinomas did not develop in the vehicle control rats). In addition, the carcinoma that developed in the rat treated with 0.25 mg POT was a squamous cell carcinoma, a tumor that develops spontaneously in about 1 per 1700 rats. The incidence of mesothelial cell hyperplasia was 4/17, 7/16, and 10/14 and the incidence of malignant mesothelioma was 3/17, 1/16, and 2/14 in the 0.25 mg POT, 0.5 mg POT, and MWCNT-7 treated groups, respectively. Neither mesothelial cell hyperplasia nor mesothelioma developed in control rats or the rats treated with r-nTiO(2). Since the incidence of spontaneously occurring malignant mesothelioma in rats is extremely low, approximately 1 per 1000 animals (Japan Bioassay Research Center [JBRC] historical control data), the development of multiple malignant mesotheliomas in the POT and MWCNT-7 treated groups was biologically significant. CONCLUSION: The incidence of pleural mesotheliomas in male F344 rats administered POT fibers and MWCNT-7 was significantly higher than the JBRC historical control data, indicating that the incidence of pleural mesothelioma in the groups administered POT fibers and MWCNT-7 fibers via the airway using TIPS was biologically significant. The incidence of type II epithelial cell hyperplasia and the histology of the carcinomas that developed in the POT treated rats also indicates that respirable POT fibers are highly likely to be carcinogenic in the lungs of male F344 rats. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12989-019-0316-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6720102
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-67201022019-09-06 Carcinogenic effect of potassium octatitanate (POT) fibers in the lung and pleura of male Fischer 344 rats after intrapulmonary administration Abdelgied, Mohamed El-Gazzar, Ahmed M. Alexander, William T. Numano, Takamasa Iigou, Masaaki Naiki-Ito, Aya Takase, Hiroshi Hirose, Akihiko Taquahashi, Yuhji Kanno, Jun Abdelhamid, Mona Abdou, Khaled Abbas Takahashi, Satoru Alexander, David B. Tsuda, Hiroyuki Part Fibre Toxicol Research BACKGROUND: Potassium octatitanate fibers (K(2)O•8TiO(2), POT fibers) are used as an asbestos substitute. Their physical characteristics suggest that respirable POT fibers are likely to be carcinogenic in the lung and pleura. However, previous 2-year inhalation studies reported that respired POT fibers had little or no carcinogenic potential. In the present study ten-week old male F344 rats were left untreated or were administered vehicle, 0.25 or 0.5 mg rutile-type nano TiO(2) (r-nTiO(2)), 0.25 or 0.5 mg POT fibers, or 0.5 mg MWCNT-7 by intra-tracheal intra-pulmonary spraying (TIPS), and then observed for 2 years. RESULTS: There were no differences between the r-nTiO(2) and control groups. The incidence of bronchiolo-alveolar cell hyperplasia was significantly increased in the groups treated with 0.50 mg POT and 0.50 mg MWCNT-7. The overall incidence of lung tumors, however, was not increased in either the POT or MWCNT-7 treated groups. Notably, the carcinomas that developed in the POT and MWCNT-7 treated rats were accompanied by proliferative fibrous connective tissue while the carcinomas that developed in the untreated rats and the r-nTiO(2) treated rats were not (carcinomas did not develop in the vehicle control rats). In addition, the carcinoma that developed in the rat treated with 0.25 mg POT was a squamous cell carcinoma, a tumor that develops spontaneously in about 1 per 1700 rats. The incidence of mesothelial cell hyperplasia was 4/17, 7/16, and 10/14 and the incidence of malignant mesothelioma was 3/17, 1/16, and 2/14 in the 0.25 mg POT, 0.5 mg POT, and MWCNT-7 treated groups, respectively. Neither mesothelial cell hyperplasia nor mesothelioma developed in control rats or the rats treated with r-nTiO(2). Since the incidence of spontaneously occurring malignant mesothelioma in rats is extremely low, approximately 1 per 1000 animals (Japan Bioassay Research Center [JBRC] historical control data), the development of multiple malignant mesotheliomas in the POT and MWCNT-7 treated groups was biologically significant. CONCLUSION: The incidence of pleural mesotheliomas in male F344 rats administered POT fibers and MWCNT-7 was significantly higher than the JBRC historical control data, indicating that the incidence of pleural mesothelioma in the groups administered POT fibers and MWCNT-7 fibers via the airway using TIPS was biologically significant. The incidence of type II epithelial cell hyperplasia and the histology of the carcinomas that developed in the POT treated rats also indicates that respirable POT fibers are highly likely to be carcinogenic in the lungs of male F344 rats. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12989-019-0316-2) contains supplementary material, which is available to authorized users. BioMed Central 2019-09-02 /pmc/articles/PMC6720102/ /pubmed/31477126 http://dx.doi.org/10.1186/s12989-019-0316-2 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Abdelgied, Mohamed
El-Gazzar, Ahmed M.
Alexander, William T.
Numano, Takamasa
Iigou, Masaaki
Naiki-Ito, Aya
Takase, Hiroshi
Hirose, Akihiko
Taquahashi, Yuhji
Kanno, Jun
Abdelhamid, Mona
Abdou, Khaled Abbas
Takahashi, Satoru
Alexander, David B.
Tsuda, Hiroyuki
Carcinogenic effect of potassium octatitanate (POT) fibers in the lung and pleura of male Fischer 344 rats after intrapulmonary administration
title Carcinogenic effect of potassium octatitanate (POT) fibers in the lung and pleura of male Fischer 344 rats after intrapulmonary administration
title_full Carcinogenic effect of potassium octatitanate (POT) fibers in the lung and pleura of male Fischer 344 rats after intrapulmonary administration
title_fullStr Carcinogenic effect of potassium octatitanate (POT) fibers in the lung and pleura of male Fischer 344 rats after intrapulmonary administration
title_full_unstemmed Carcinogenic effect of potassium octatitanate (POT) fibers in the lung and pleura of male Fischer 344 rats after intrapulmonary administration
title_short Carcinogenic effect of potassium octatitanate (POT) fibers in the lung and pleura of male Fischer 344 rats after intrapulmonary administration
title_sort carcinogenic effect of potassium octatitanate (pot) fibers in the lung and pleura of male fischer 344 rats after intrapulmonary administration
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720102/
https://www.ncbi.nlm.nih.gov/pubmed/31477126
http://dx.doi.org/10.1186/s12989-019-0316-2
work_keys_str_mv AT abdelgiedmohamed carcinogeniceffectofpotassiumoctatitanatepotfibersinthelungandpleuraofmalefischer344ratsafterintrapulmonaryadministration
AT elgazzarahmedm carcinogeniceffectofpotassiumoctatitanatepotfibersinthelungandpleuraofmalefischer344ratsafterintrapulmonaryadministration
AT alexanderwilliamt carcinogeniceffectofpotassiumoctatitanatepotfibersinthelungandpleuraofmalefischer344ratsafterintrapulmonaryadministration
AT numanotakamasa carcinogeniceffectofpotassiumoctatitanatepotfibersinthelungandpleuraofmalefischer344ratsafterintrapulmonaryadministration
AT iigoumasaaki carcinogeniceffectofpotassiumoctatitanatepotfibersinthelungandpleuraofmalefischer344ratsafterintrapulmonaryadministration
AT naikiitoaya carcinogeniceffectofpotassiumoctatitanatepotfibersinthelungandpleuraofmalefischer344ratsafterintrapulmonaryadministration
AT takasehiroshi carcinogeniceffectofpotassiumoctatitanatepotfibersinthelungandpleuraofmalefischer344ratsafterintrapulmonaryadministration
AT hiroseakihiko carcinogeniceffectofpotassiumoctatitanatepotfibersinthelungandpleuraofmalefischer344ratsafterintrapulmonaryadministration
AT taquahashiyuhji carcinogeniceffectofpotassiumoctatitanatepotfibersinthelungandpleuraofmalefischer344ratsafterintrapulmonaryadministration
AT kannojun carcinogeniceffectofpotassiumoctatitanatepotfibersinthelungandpleuraofmalefischer344ratsafterintrapulmonaryadministration
AT abdelhamidmona carcinogeniceffectofpotassiumoctatitanatepotfibersinthelungandpleuraofmalefischer344ratsafterintrapulmonaryadministration
AT abdoukhaledabbas carcinogeniceffectofpotassiumoctatitanatepotfibersinthelungandpleuraofmalefischer344ratsafterintrapulmonaryadministration
AT takahashisatoru carcinogeniceffectofpotassiumoctatitanatepotfibersinthelungandpleuraofmalefischer344ratsafterintrapulmonaryadministration
AT alexanderdavidb carcinogeniceffectofpotassiumoctatitanatepotfibersinthelungandpleuraofmalefischer344ratsafterintrapulmonaryadministration
AT tsudahiroyuki carcinogeniceffectofpotassiumoctatitanatepotfibersinthelungandpleuraofmalefischer344ratsafterintrapulmonaryadministration